![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
InvivoSciences, LLC
University Research Park
510 Charmany Drive
Suite 265
Madison, WI 53719-1235
1-414-921-0364
info@invivosciences.com
InvivoSciences awarded NIH SBIR/STTR Phase II Grant for engineered tissue-based, high-throughput compound profiling
InvivoSciences'
Award Winning Technologies
Small Business Innovation Award For Outstanding Achievements

|
|
|
Discover InvivoSciences3D cell culture tools and assay systems for compound screening and regenerative medicine development |
InvivoSciences provides alternatives to animal testing for the cosmetic and consumer goods industries
Late-Stage Drug Failures Prompt Push for More Effective Approaches to Designing Therapies
Optimising methods and integrating new platforms for drug discovery, development and toxicity testing
Join us at the Experimental Biology 2011 conference at the Walter E. Washington Convention Center. Visit us at booth #540 or catch our presentation of high-throughput toxic compound screening of engineered heart tissues (EHTs) on April 12th, 10:25 am - 10:40 am, Room 207B. We will also have a poster presentation, B396, on April 10th, 1:05-2:35pm. See you there!
Advances in cell-based assays aim to detect more subtle toxicities often not seen until later-stage drug screening.
BIO International Convention Rave Reviews
Executives express the benefits of the BIO Organization
The annual summit focuses on the advance of drug discovery through scientific innovation & strategy. InvivoSciences LLC, among other sponsors, will lead a talk on Engineered Tissue Based-Drug Discovery
Cell-Based Assays Conference Overview
Hilton London Olympia will host Visiongain's Cell Based Assays conference. InvivoSciences' Chief Scientific Officer, Dr. Tetsuro Wakatsuki, will speak on 3D cell culture systems and their applications in drug discovery and beyond.
In the cover story executives look back and share what they learned from business school. See pg. 32 for response by CEO Ayla Annac.
Company co-founder, Tetsuro Wakatsuki, Ph.D., CSO, will speak during the Drug Safety Summit's Monitoring Cardiotoxicity and Drug Safety session. The topic focuses on novel in vitro approaches for assessing cardiac liabilities.
InvivoSciences LLC has been invited by BIO to present again during BIO2010 at Chicago. Come and see our presentation May 5th at 3pm in Room C or visit us at Booth #4307.
Bioforward Small Business Scholarship Awards
See p.25 (S23) for feature article on InvivoSciences LLC
Lieutenant Governor Barbara Lawton today commended InvivoSciences LLC., a women-led bioscience company based in Wauwatosa, for its selection as one of the top three most promising technologies in the United States at the Worlds Best Technology Showcase (WBTshowcase) in Arlington, Texas. Investors, licensing scouts and tech-commercialization experts from across the country selected InvivoSciences from a pool of 450 technology companies to receive its gold prize. InvivoSciences earned additional recognition last month when Bioforward selected it as the winner of its 2009 Emerging Biotechnology Showcase.